Apellis Pharmaceuticals Inc. logo

Apellis Pharmaceuticals Inc. (APLS)

Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS)
$
41. 03
0
0%
$
5.25B Market Cap
- P/E Ratio
- Div Yield
28.64M Volume
-4.51 Eps
$ 41.03
Previous Close
Day Range
41.03 41.05
Year Range
16.61 41.14
Want to track APLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Apellis Pharmaceuticals Inc. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
AR
Anupam Rama JP Morgan
654.06 $3,613.19 $2,341.53 -$1,271.66 -35.19%
EM
Eliana Merle Barclays
1,045.37 $24,992.78 $3,742.42 -$21,250.36 -85.03%
JS
Joseph Stringer Needham
10,868.51 $36,689.36 $38,909.26 $2,219.9 6.05%
YN
Yigal Nochomovitz Citigroup
142.05 $485.03 $508.53 $23.5 4.85%